Drug Profile
CGS 24012
Alternative Names: DPMA; PD 125944Latest Information Update: 11 Jun 2001
Price :
$50
*
At a glance
- Originator Novartis
- Class Antihypertensives; Heart failure therapies
- Mechanism of Action Adenosine A2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure
- Discontinued Hypertension
Most Recent Events
- 11 Jun 2001 Discontinued-Preclinical for Hypertension in USA (Unknown route)
- 11 Jun 2001 No-Development-Reported for Congestive heart failure in USA (Unknown route)
- 01 Apr 1998 Preclinical development for Congestive heart failure in USA (Unknown route)